NYNOMIC AG (M7U.DE) Stock Fundamental Analysis

FRA:M7U • DE000A0MSN11

9.94 EUR
+0.04 (+0.4%)
Last: Feb 18, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, M7U scores 4 out of 10 in our fundamental rating. M7U was compared to 54 industry peers in the Electronic Equipment, Instruments & Components industry. M7U has only an average score on both its financial health and profitability. M7U is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year M7U has reported negative net income.
  • M7U had a positive operating cash flow in the past year.
  • Of the past 5 years M7U 4 years were profitable.
  • M7U had a positive operating cash flow in each of the past 5 years.
M7U.DE Yearly Net Income VS EBIT VS OCF VS FCFM7U.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

1.2 Ratios

  • M7U has a Return On Assets of -5.07%. This is in the lower half of the industry: M7U underperforms 68.52% of its industry peers.
  • With a Return On Equity value of -7.06%, M7U is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • M7U's Return On Invested Capital of 0.70% is on the low side compared to the rest of the industry. M7U is outperformed by 61.11% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for M7U is in line with the industry average of 7.38%.
  • The 3 year average ROIC (7.47%) for M7U is well above the current ROIC(0.70%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -5.07%
ROE -7.06%
ROIC 0.7%
ROA(3y)3.69%
ROA(5y)4.37%
ROE(3y)6.44%
ROE(5y)8.2%
ROIC(3y)7.47%
ROIC(5y)7.55%
M7U.DE Yearly ROA, ROE, ROICM7U.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • The Operating Margin of M7U (1.22%) is comparable to the rest of the industry.
  • M7U's Operating Margin has declined in the last couple of years.
  • M7U has a Gross Margin of 63.16%. This is amongst the best in the industry. M7U outperforms 83.33% of its industry peers.
  • M7U's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.22%
PM (TTM) N/A
GM 63.16%
OM growth 3Y-16.45%
OM growth 5Y-6.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.22%
GM growth 5Y0.66%
M7U.DE Yearly Profit, Operating, Gross MarginsM7U.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so M7U is still creating some value.
  • Compared to 1 year ago, M7U has about the same amount of shares outstanding.
  • Compared to 5 years ago, M7U has more shares outstanding
  • The debt/assets ratio for M7U has been reduced compared to a year ago.
M7U.DE Yearly Shares OutstandingM7U.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
M7U.DE Yearly Total Debt VS Total AssetsM7U.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • An Altman-Z score of 2.72 indicates that M7U is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.72, M7U perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • The Debt to FCF ratio of M7U is 6.81, which is on the high side as it means it would take M7U, 6.81 years of fcf income to pay off all of its debts.
  • M7U has a Debt to FCF ratio (6.81) which is comparable to the rest of the industry.
  • M7U has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of M7U (0.14) is better than 74.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.81
Altman-Z 2.72
ROIC/WACC0.11
WACC6.35%
M7U.DE Yearly LT Debt VS Equity VS FCFM7U.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 3.16 indicates that M7U has no problem at all paying its short term obligations.
  • M7U's Current ratio of 3.16 is amongst the best of the industry. M7U outperforms 90.74% of its industry peers.
  • A Quick Ratio of 1.49 indicates that M7U should not have too much problems paying its short term obligations.
  • M7U's Quick ratio of 1.49 is fine compared to the rest of the industry. M7U outperforms 79.63% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 1.49
M7U.DE Yearly Current Assets VS Current LiabilitesM7U.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

3

3. Growth

3.1 Past

  • The earnings per share for M7U have decreased strongly by -169.33% in the last year.
  • The Revenue for M7U has decreased by -14.11% in the past year. This is quite bad
  • The Revenue has been growing by 9.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-169.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.97%
Revenue 1Y (TTM)-14.11%
Revenue growth 3Y-0.85%
Revenue growth 5Y9.57%
Sales Q2Q%-11.57%

3.2 Future

  • M7U is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.60% yearly.
  • M7U is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y-83.33%
EPS Next 2Y7%
EPS Next 3Y12.6%
EPS Next 5YN/A
Revenue Next Year-9.85%
Revenue Next 2Y-2.03%
Revenue Next 3Y1.1%
Revenue Next 5Y6.3%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
M7U.DE Yearly Revenue VS EstimatesM7U.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
M7U.DE Yearly EPS VS EstimatesM7U.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for M7U. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 12.46, the valuation of M7U can be described as correct.
  • Based on the Price/Forward Earnings ratio, M7U is valued a bit cheaper than 68.52% of the companies in the same industry.
  • M7U is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 12.46
M7U.DE Price Earnings VS Forward Price EarningsM7U.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • M7U's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. M7U is cheaper than 66.67% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as M7U.
Industry RankSector Rank
P/FCF 25.64
EV/EBITDA 10.4
M7U.DE Per share dataM7U.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as M7U's earnings are expected to grow with 12.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7%
EPS Next 3Y12.6%

0

5. Dividend

5.1 Amount

  • No dividends for M7U!.
Industry RankSector Rank
Dividend Yield 0%

NYNOMIC AG

FRA:M7U (2/18/2026, 7:00:00 PM)

9.94

+0.04 (+0.4%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-28
Earnings (Next)03-31
Inst Owners20.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap65.31M
Revenue(TTM)96.90M
Net Income(TTM)-6.64M
Analysts83.33
Price Target19.89 (100.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.13
Dividend Growth(5Y)-3.19%
DP-13.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-74.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.46
P/S 0.67
P/FCF 25.64
P/OCF 11.7
P/B 0.69
P/tB 1.41
EV/EBITDA 10.4
EPS(TTM)-1
EYN/A
EPS(NY)0.8
Fwd EY8.03%
FCF(TTM)0.39
FCFY3.9%
OCF(TTM)0.85
OCFY8.55%
SpS14.75
BVpS14.33
TBVpS7.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -7.06%
ROCE 1.06%
ROIC 0.7%
ROICexc 0.79%
ROICexgc 1.51%
OM 1.22%
PM (TTM) N/A
GM 63.16%
FCFM 2.63%
ROA(3y)3.69%
ROA(5y)4.37%
ROE(3y)6.44%
ROE(5y)8.2%
ROIC(3y)7.47%
ROIC(5y)7.55%
ROICexc(3y)9.51%
ROICexc(5y)9.95%
ROICexgc(3y)21.63%
ROICexgc(5y)23.74%
ROCE(3y)11.26%
ROCE(5y)11.38%
ROICexgc growth 3Y-34.01%
ROICexgc growth 5Y-22.69%
ROICexc growth 3Y-26.92%
ROICexc growth 5Y-11.28%
OM growth 3Y-16.45%
OM growth 5Y-6.15%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.22%
GM growth 5Y0.66%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 6.81
Debt/EBITDA 2.02
Cap/Depr 55.21%
Cap/Sales 3.13%
Interest Coverage 2.82
Cash Conversion 83.52%
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 1.49
Altman-Z 2.72
F-Score4
WACC6.35%
ROIC/WACC0.11
Cap/Depr(3y)106.93%
Cap/Depr(5y)82.07%
Cap/Sales(3y)4.46%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-169.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-206.97%
EPS Next Y-83.33%
EPS Next 2Y7%
EPS Next 3Y12.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.11%
Revenue growth 3Y-0.85%
Revenue growth 5Y9.57%
Sales Q2Q%-11.57%
Revenue Next Year-9.85%
Revenue Next 2Y-2.03%
Revenue Next 3Y1.1%
Revenue Next 5Y6.3%
EBIT growth 1Y-92.11%
EBIT growth 3Y-17.16%
EBIT growth 5Y2.83%
EBIT Next Year-13.99%
EBIT Next 3Y28.46%
EBIT Next 5YN/A
FCF growth 1Y265.93%
FCF growth 3Y-38.75%
FCF growth 5Y11.02%
OCF growth 1Y321.04%
OCF growth 3Y-25%
OCF growth 5Y12.14%

NYNOMIC AG / M7U.DE FAQ

What is the ChartMill fundamental rating of NYNOMIC AG (M7U.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to M7U.DE.


What is the valuation status of NYNOMIC AG (M7U.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to NYNOMIC AG (M7U.DE). This can be considered as Overvalued.


How profitable is NYNOMIC AG (M7U.DE) stock?

NYNOMIC AG (M7U.DE) has a profitability rating of 4 / 10.


How sustainable is the dividend of NYNOMIC AG (M7U.DE) stock?

The dividend rating of NYNOMIC AG (M7U.DE) is 0 / 10 and the dividend payout ratio is -13.84%.